Name | 1,3-Benzothiazol-2-yl(2-chloro-4-pyrimidinyl)acetonitrile |
---|---|
Synonyms |
Benzothiazole,2-[(phenylmethyl)sulfonyl]
2-phenylmethanesulfonyl-benzothiazole 1,3-benzothiazol-2-yl(2-chloro-4-pyrimidinyl)-acetonitrile 2-Phenylmethansulfonyl-benzothiazol 1,3-benzothiazol-2-yl benzyl sulfone benzothiazol-2-yl-(2-chloro-pyrimidin-4-yl)-acetonitrile 2-<(phenylmethyl)sulfonyl>benzothiazole 2-(benzylsulfonyl)benzothiazole benzothiazol-2-benzyl sulfone 2-(benzylsulfonyl)benzo[d]thiazole |
Description | JNK-IN-13 (compound 1) is a potent and selective JNK inhibitor with IC50s of 290 nM and 500 nM for JNK3 and JNK2, respectively[1]. |
---|---|
Related Catalog | |
Target |
JNK2:500 nM (IC50) JNK3:290 nM (IC50) |
References |
[1]. Serge Halazy, et al. Benzazole derivatives and their use as JNK modulators. EP1110957A1. |
Molecular Formula | C13H7ClN4S |
---|---|
Molecular Weight | 286.74 |
Exact Mass | 286.00800 |
PSA | 90.70000 |
LogP | 3.39518 |
~84% 345986-38-1 |
Literature: ARES TRADING S.A. Patent: US2008/51397 A1, 2008 ; Location in patent: Page/Page column 21 ; |
Precursor 2 | |
---|---|
DownStream 0 |